Previous Close | 4.0600 |
Open | 4.0800 |
Bid | 4.3700 x 600 |
Ask | 4.4000 x 1000 |
Day's Range | 4.0650 - 4.5000 |
52 Week Range | 1.5000 - 5.2200 |
Volume | |
Avg. Volume | 2,224,364 |
Market Cap | 3.082B |
Beta (5Y Monthly) | -1.20 |
PE Ratio (TTM) | 11.55 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements.
Q1 2024 Summit Therapeutics Inc Earnings Call